AllianceBernstein’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $514K | Sell |
61,330
-3,400
| -5% | -$28.2K | ﹤0.01% | 2693 |
|
|
2026
Q1 | $932K | Hold |
64,730
| – | – | ﹤0.01% | 2371 |
|
|
2025
Q4 | $932K | Hold |
64,730
| – | – | ﹤0.01% | 2379 |
|
|
2025
Q3 | $625K | Hold |
64,730
| – | – | ﹤0.01% | 2564 |
|
|
2025
Q2 | $531K | Buy |
64,730
+11,830
| +22% | +$99K | ﹤0.01% | 2611 |
|
|
2025
Q1 | $378K | Sell |
52,900
-1,000
| -2% | -$7.44K | ﹤0.01% | 2661 |
|
|
2024
Q4 | $417K | Sell |
53,900
-5,127
| -9% | -$48.1K | ﹤0.01% | 2719 |
|
|
2024
Q3 | $619K | Hold |
59,027
| – | – | ﹤0.01% | 2561 |
|
|
2024
Q2 | $691K | Hold |
59,027
| – | – | ﹤0.01% | 2490 |
|
|
2024
Q1 | $1.24M | Sell |
59,027
-513
| -0.9% | -$9.13K | ﹤0.01% | 2144 |
|
|
2023
Q4 | $1.07M | Sell |
59,540
-1,180
| -2% | -$20.8K | ﹤0.01% | 2242 |
|
|
2023
Q3 | $999K | Hold |
60,720
| – | – | ﹤0.01% | 2249 |
|
|
2023
Q2 | $1.21M | Sell |
60,720
-50,000
| -45% | -$963K | ﹤0.01% | 2172 |
|
|
2023
Q1 | $2.09M | Buy |
110,720
+44,441
| +67% | +$983K | ﹤0.01% | 1843 |
|
|
2022
Q4 | $1.5M | Buy |
66,279
+42
| +0.1% | +$949 | ﹤0.01% | 2075 |
|
|
2022
Q3 | $1.75M | Sell |
66,237
-2
| -0% | -$59 | ﹤0.01% | 1970 |
|
|
2022
Q2 | $1.64M | Sell |
66,239
-1,402
| -2% | -$35K | ﹤0.01% | 2072 |
|
|
2022
Q1 | $2.25M | Buy |
67,641
+154
| +0.2% | +$4.28K | ﹤0.01% | 2020 |
|
|
2021
Q4 | $2.21M | Sell |
67,487
-893
| -1% | -$30.4K | ﹤0.01% | 2076 |
|
|
2021
Q3 | $2.87M | Sell |
68,380
-1,280
| -2% | -$46.1K | ﹤0.01% | 1944 |
|
|
2021
Q2 | $2.71M | Buy |
69,660
+8,420
| +14% | +$301K | ﹤0.01% | 2003 |
|
|
2021
Q1 | $2.09M | Buy |
61,240
+1,970
| +3% | +$84K | ﹤0.01% | 2080 |
|
|
2020
Q4 | $2.69M | Hold |
59,270
| – | – | ﹤0.01% | 1814 |
|
|
2020
Q3 | $1.63M | Sell |
59,270
-4,270
| -7% | -$139K | ﹤0.01% | 1952 |
|
|
2020
Q2 | $2.34M | Sell |
63,540
-660
| -1% | -$24.6K | ﹤0.01% | 1756 |
|
|
2020
Q1 | $2.08M | Buy |
64,200
+1,350
| +2% | +$56.2K | ﹤0.01% | 1650 |
|
|
2019
Q4 | $2.58M | Buy |
62,850
+200
| +0.3% | +$7.9K | ﹤0.01% | 1825 |
|
|
2019
Q3 | $2.23M | Sell |
62,650
-42,980
| -41% | -$1.74M | ﹤0.01% | 1864 |
|
|
2019
Q2 | $5.43M | Buy |
105,630
+24,800
| +31% | +$1.24M | ﹤0.01% | 1371 |
|
|
2019
Q1 | $4.63M | Sell |
80,830
-99,100
| -55% | -$4.91M | ﹤0.01% | 1420 |
|
|
2018
Q4 | $7.55M | Buy |
179,930
+104,510
| +139% | +$6.13M | 0.01% | 1109 |
|
|
2018
Q3 | $5.69M | Sell |
75,420
-15,810
| -17% | -$1.14M | ﹤0.01% | 1212 |
|
|
2018
Q2 | $6.55M | Buy |
91,230
+63,830
| +233% | +$3.05M | ﹤0.01% | 1118 |
|
|
2018
Q1 | $818K | Hold |
27,400
| – | – | ﹤0.01% | 2349 |
|
|
2017
Q4 | $911K | Hold |
27,400
| – | – | ﹤0.01% | 2326 |
|
|
2017
Q3 | $903K | Buy |
27,400
+10,300
| +60% | +$232K | ﹤0.01% | 2326 |
|
|
2017
Q2 | $338K | Buy |
+17,100
| New | +$331K | ﹤0.01% | 2768 |
|
Other funds holding RGNX
RG
AllianceBernstein's RGNX Position: Q2 2026 in Review
AllianceBernstein reduced its Regenxbio (RGNX) stake by 5.3% in Q2 2026, selling an estimated $28.2K and leaving 61,330 shares worth $514K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.
AllianceBernstein first reported a position in RGNX in Q2 2017 and has held it in 37 quarters since. The position peaked at $7.55M in Q4 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- AllianceBernstein held 61,330 shares of Regenxbio worth $514K as of Q2 2026.
- AllianceBernstein sold 3,400 Regenxbio shares in Q2 2026, an estimated $28.2K.
- Regenxbio made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2693 holding.
- AllianceBernstein first reported a position in Regenxbio in Q2 2017 and has held it in 37 quarters since.
- AllianceBernstein's Regenxbio position peaked at $7.55M in Q4 2018.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.